Asia-Pacific Americas Africa Europe Middle East

NEXT PHARMACEUTICAL PRODUCTS PRIVATE LIMITED

Company Profile:

Country: Pakistan

Company Type: Manufacturer

Company Introduction:

NEXT PHARMACEUTICAL PRODUCTS PRIVATE LIMITED is a pharmaceutical manufacturing company based in Pakistan. It is dedicated to the production of a diverse range of pharmaceutical formulations, adhering to international quality standards and regulatory guidelines. The company focuses on developing, producing, and distributing high-quality and affordable medicines to meet the healthcare needs of the population.

With its manufacturing facilities, NEXT PHARMACEUTICAL PRODUCTS PRIVATE LIMITED is involved in the complete process of drug production, from raw material sourcing and formulation to packaging and distribution. Its operations emphasize stringent quality control measures to ensure the efficacy, safety, and reliability of its products. The company plays an important role in the Pakistani pharmaceutical industry by contributing to the availability of essential medicines.

Enterprise Products

NEXT PHARMACEUTICAL PRODUCTS PRIVATE LIMITED in Pakistan manufactures or sells a variety of pharmaceutical products. These include Nexpro (Esomeprazole), Nexpro RD (Esomeprazole and Domperidone), Next-D (Domperidone), Nextgesic (Diclofenac Sodium), Nextdol (Tramadol), Nextflam (Diclofenac Potassium), Nextcef (Cefixime), Nextclav (Amoxicillin and Clavulanic Acid), Nextcin (Azithromycin), Nextcal (Calcium and Vitamin D3), Nextvit (Multivitamin), Nextmet (Metoprolol), Nextar (Rosuvastatin), Nextaller (Fexofenadine), Nextril (Levocetirizine), Nextcalm (Alprazolam), Nextrin (Escitalopram), and Nextiler (Salbutamol).

Business Registration Information:

Manager:

Muhammad Danish Iqbal (Chief Executive Officer)

Phone:

+92 21 35061618-20

E-mail:

info@nextpharma.com.pk

Official Website:
Address:

Plot No. 16, Sector 23, Korangi Industrial Area, Karachi-74900, Pakistan

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.